Based on our expertise in the field of molecular and functional characterization of different cancers, we are active in numerous national and international networks. In this way, we pursue the goal of enabling cross-site collaboration to accelerate the development of precision oncology as to offer as many patients as possible individualized therapy tailored to the respective disease profile in the future.